LOFIBRA Trademark

Trademark Overview


On Thursday, July 25, 2002, a trademark application was filed for LOFIBRA with the United States Patent and Trademark Office. The USPTO has given the LOFIBRA trademark a serial number of 78147611. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The LOFIBRA trademark is filed in the Pharmaceutical Products category with the following description:

PRESCRIPTION DRUGS FOR LOWERING PLASMA TRIGLYCERIDES
lofibra

General Information


Serial Number78147611
Word MarkLOFIBRA
Filing DateThursday, July 25, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number2721535
Registration DateTuesday, June 3, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 11, 2003

Trademark Statements


Goods and ServicesPRESCRIPTION DRUGS FOR LOWERING PLASMA TRIGLYCERIDES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateTuesday, September 3, 2002
First Use In Commerce DateTuesday, September 3, 2002

Trademark Owner History


Party NameRHODES PHARMACEUTICALS L.P.
Party Type34 - New Owner After Registration
Legal Entity Type99 - Other
AddressCOVENTRY, RI 02816

Party NameRHODES PHARMACEUTICALS L.P.
Party Type33 - New Owner After Registration
Legal Entity Type13 - Limited Partnership
AddressCOVENTRY, RI 02816

Party NameTeva Canada Limited
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTORONTO M1B 2K9
CA

Party NameNOVOPHARM LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTORONTO M1B 2K9
CA

Party NameTeva Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090

Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090

Trademark Events


Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Friday, June 3, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, July 29, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 15, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 15, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 7, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, May 3, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, May 3, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 3, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, May 2, 2013TEAS SECTION 8 & 9 RECEIVED
Monday, June 28, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 28, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 4, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 29, 2009ASSIGNED TO PARALEGAL
Thursday, January 22, 2009TEAS SECTION 8 & 15 RECEIVED
Friday, April 11, 2008CASE FILE IN TICRS
Tuesday, June 3, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, March 11, 2003PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2003NOTICE OF PUBLICATION
Friday, January 17, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 17, 2003USE AMENDMENT ACCEPTED
Tuesday, January 14, 2003AMENDMENT TO USE PROCESSING COMPLETE
Monday, December 16, 2002USE AMENDMENT FILED
Tuesday, January 14, 2003ASSIGNED TO EXAMINER
Monday, December 16, 2002PAPER RECEIVED